𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Localization and functional roles of corticotropin-releasing factor receptor type 2 in the cerebellum

✍ Scribed by Natalia V. Gounko; Albert Gramsbergen; Johannes J. L. van der Want

Book ID
107648188
Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
254 KB
Volume
7
Category
Article
ISSN
1473-4222

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Evidence for the presence of the type 2
Evidence for the presence of the type 2 corticotropin releasing factor receptor in the rodent cerebellum
✍ Georgia A. Bishop; Jin Bin Tian; Jennifer J. Stanke; Andy J. Fischer; James S. K πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 989 KB

## Abstract Corticotropin releasing factor (CRF), localized in afferent inputs to the cerebellum, binds to two receptors defined as the Type 1 (CRF‐R1) and the Type 2 (CRF‐R2Ξ±). CRF‐R1 has been localized to the cerebellum, as has a truncated isoform of CRF‐R2Ξ±. Evidence for the presence of the full

Cellular localization of the full-length
Cellular localization of the full-length isoform of the type 2 corticotropin releasing factor receptor in the postnatal mouse cerebellar cortex
✍ Kyung-Hoon Lee; Georgia A. Bishop; Jin Bin Tian; Yoon-Jin Jang; Bao Chi Bui; Tru πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 660 KB

## Abstract Corticotropin releasing factor (CRF) and its cognate receptors, defined as Type 1 and Type 2 have been localized within the cerebellum. The Type 2 CRF receptor (CRF‐R2) is known to have both a full length (CRF‐R2Ξ±) and a truncated (CRF‐R2α‐tr) isoform. A recent study documented CRF‐R2Ξ±

Corticotropin-releasing factor (CRF) rec
Corticotropin-releasing factor (CRF) receptor type 2 in the human stomach: Protective biological role by inhibition of apoptosis
✍ Ekaterini Chatzaki; Maria Lambropoulou; Theodoros C. Constantinidis; Nikolaos Pa πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 312 KB

## Abstract Corticotropin‐releasing factor agonists exert inhibitory effects in stomach functions possibly through peripheral routes. We have previously reported the expression of Urocortin (Ucn) I, an endogenous ligand of both CRF receptor types CRF~1~ and CRF~2~, in the human stomach. We examined